Physician profile
Ginger A Allen
NPI 1568490340
$6,199.19
in general payments reported to CMS, 2019-2025
18 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,153 · 2020: $29.44 · 2021: $71.06 · 2022: $362 · 2023: $326 · 2024: $107 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $5,084.73 | 2019-2022 | |
| Abbvie INC. | $229.86 | 2019-2025 | Qulipta, Ubrelvy |
| Astellas Pharma US INC | $194.28 | 2019-2025 | Veozah |
| Pfizer INC. | $147.02 | 2019-2025 | |
| Novo Nordisk INC | $117.00 | 2019-2023 | Wegovy |
| Amgen INC. | $80.80 | 2019-2025 | Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $60.37 | 2022-2023 | Eliquis |
| Organon LLC | $49.01 | 2021-2024 | |
| Quidel Corporation | $45.25 | 2023 | |
| Lucid Diagnostics INC. | $33.65 | 2022-2023 | |
| Stryker Corporation | $30.90 | 2025 | Mako |
| Biohaven Pharmaceutical Holding Company LTD. | $27.59 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.56 | 2024 | |
| Corcept Therapeutics | $18.68 | 2025 | Korlym |
| Mayne Pharma Commercial LLC | $18.02 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.95 | 2025 | General - Pain Management |
| Sonex Health, INC. | $13.55 | 2025 | Sx-One Microknife |
| Astrazeneca Pharmaceuticals LP | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.